Inactivation of LRRC4 in Gliomas Due to Methylation
Author Information
Author(s): Zhang Zuping, Li Dan, Wu Minghua, Xiang Bo, Wang Li, Zhou Ming, Chen Pan, Li Xiaoling, Shen Shourong, Li Guiyuan
Primary Institution: Cancer Research Institute, Central South University, Changsha, Hunan, PR China
Hypothesis
The study investigates the role of promoter hypermethylation in the inactivation of the LRRC4 gene in gliomas.
Conclusion
Methylation-mediated inactivation of LRRC4 is a frequent and glioma-specific event, potentially serving as a biomarker for diagnosis and prognosis.
Supporting Evidence
- LRRC4 promoter activity is suppressed after treatment with methylation agents.
- All 30 primary glioma specimens showed LRRC4 promoter methylation.
- LRRC4 expression was restored in glioma cells treated with a demethylating agent.
Takeaway
The study found that a gene called LRRC4, which helps prevent tumors, is often turned off in brain cancer due to a process called methylation.
Methodology
The researchers cloned the LRRC4 promoter and examined its methylation status in glioma cell lines and primary gliomas using methylation-specific PCR and bisulfite DNA sequencing.
Limitations
The study may not account for all potential genetic and environmental factors influencing LRRC4 expression.
Participant Demographics
The study included 30 patients (17 male and 13 female) aged 17 to 68 years with various grades of gliomas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website